Top

Current Bladder Dysfunction Reports

Published in:

01-04-2023 | Benign Prostatic Hypertrophy

Moses Laser Enucleation of the Prostate (MoLEP): Use of Pulse Modulated Holmium Laser Technology for Prostate Enucleation

Authors: Mark A. Assmus, Amy E. Krambeck

Published in: Current Bladder Dysfunction Reports | Issue 2/2023

Abstract

Purpose of Review

In this review, the current literature available that evaluates the use of Moses pulse-modulated holmium technology for laser enucleation of the prostate will be addressed. Topics include safety and surgical case efficiency, length of post-operative foley catheter and hospital stay, surgical outcomes, and areas of future research.

Recent Findings

Some early retrospective studies and select randomized control trials seek to determine if novel laser technologies can improve peri-operative outcome measures or reduce the morbidity of endoscopic enucleation of the prostate while maintaining or improving the safety profile of holmium laser enucleation of the prostate (HoLEP). Both objective and subjective outcomes of HoLEP are seen to be preserved in patients undergoing Moses laser enucleation of the prostate (MoLEP), with recent studies highlighting high rates of successful same-day catheter removal and same-day discharge in an increasingly wide range of patients.

Summary

Initial studies focusing on Moses laser technology for prostate enucleation are promising. Further high-quality randomized controlled trials evaluating MoLEP are required to clarify the clinical impact of this laser technology on prostate enucleation outcomes as well as comparing to alternative novel benign prostate hyperplasia (BPH) treatments.

Egan KB. The epidemiology of benign prostatic hyperplasia associated with lower urinary tract symptoms: prevalence and incident rates. Urol Clin North Am. 2016;43(3):289–97.PubMedCrossRef

Gratzke C, Bachmann A, Descazeaud A, Drake MJ, Madersbacher S, Mamoulakis C, Oelke M, Tikkinen KAO, Gravas S. EAU Guidelines on the Assessment of Non-neurogenic Male Lower Urinary Tract Symptoms including Benign Prostatic Obstruction. Eur Urol. 2015;67(6):1099–109. https://doi.org/10.1016/j.eururo.2014.12.038.PubMedCrossRef

Lerner LB, McVary KT, Barry MJ, Bixler BR, Dahm P, Das AK, et al. Management of lower urinary tract symptoms attributed to benign prostatic hyperplasia: AUA GUIDELINE PART II-surgical evaluation and treatment. J Urol. 2021;206(4):818–26.PubMedCrossRef

Nickel JC, Aaron L, Barkin J, Elterman D, Nachabe M, Zorn KC. Canadian urological association guideline on male lower urinary tract symptoms/benign prostatic hyperplasia (MLUTS/BPH): 2018 update. Can Urol Assoc J. 2018;12(10):303–12.PubMedPubMedCentralCrossRef

National Institute for health and Care Exellence (NICE). Lower urinary tract symptoms in men: management. Clinical Guidelines. 2010. www.nice.orguk/guidance/cg97.

Bormashenko E. Moses effect: physics and applications. Adv Colloid Interface Sci. 2019;269:1–6.PubMedCrossRef

Fried NM, Irby PB. Advances in laser technology and fibre-optic delivery systems in lithotripsy. Nat Rev Urol. 2018;15(9):563–73.PubMedCrossRef

Corsini C, de Angelis M, Villa L, Somani BK, Pietropaolo A, Montorsi F, et al. Holmium: yttrium-aluminum-garnet laser with Moses: does it make a difference? Curr Opin Urol. 2022;32(3):324–9.PubMedCrossRef

Ventimiglia E, Traxer O. What is moses effect: a historical perspective. J Endourol. 2019;33(5):353–7.PubMedCrossRef

10.

Ventimiglia E, Villa L, Doizi S, Briganti A, Proietti S, Giusti G, et al. Laser lithotripsy: the importance of peak power and pulse modulation. Eur Urol Focus. 2021;7(1):22–5.PubMedCrossRef

11.

Elhilali MM, Badaan S, Ibrahim A, Andonian S. Use of the moses technology to improve holmium laser lithotripsy outcomes: a preclinical study. J Endourol. 2017;31(6):598–604.PubMedPubMedCentralCrossRef

12.

Ibrahim A, Badaan S, Elhilali MM, Andonian S. Moses technology in a stone simulator. Can Urol Assoc J. 2018;12(4):127–30.PubMedCrossRef

13.

Assmus MA, Lee MS, Krambeck AE. Moses laser enucleation of the prostate (MoLEP). Urol Vid J. 2022;13:10023.

14.

Agarwal DK, Rivera ME, Nottingham CU, Large T, Krambeck AE. Catheter removal on the same day of holmium laser enucleation of the prostate: outcomes of a pilot study. Urology. 2020;146:225–9.PubMedCrossRef

15.

Abdul-Muhsin H, Critchlow W, Navaratnam A, Gnecco J, Tay K, Girardo M, et al. Feasibility of holmium laser enucleation of the prostate as a 1-day surgery. World J Urol. 2020;38(4):1017–25.PubMedCrossRef

16.

Agarwal DK, Large T, Tong Y, Stoughton CL, Damler EM, Nottingham CU, et al. Same day discharge is a successful approach for the majority of patients undergoing holmium laser enucleation of the prostate. Eur Urol Focus. 2022;8(1):228–34.PubMedCrossRef

17.

Assmus MA, Ganesh MB, Lee MS, Large T, Krambeck AE. Contemporary outcomes for patients undergoing concurrent surgeries at the time of holmium laser enucleation of the prostate before and after moses 2.0 BPH mode. J Endourol. 2021;35(S3):S8–13.PubMedCrossRef

18.

Assmus MA, Large T, Lee MS, Agarwal DK, Rivera ME, Krambeck AE. Same-day discharge following holmium laser enucleation in patients assessed to have large gland prostates (>/=175 cc). J Endourol. 2021;35(9):1386–92.PubMedCrossRef

19.

Li J, Cao D, Huang Y, Liu L, Wei Q. Re: Does MOSES technology enhance the efficiency and outcomes of standard holmium laser enucleation of the prostate? Results of a systematic review and meta-analysis of comparative studies. Eur Urol Focus. 2022;8(6):1869–70.PubMedCrossRef

20.

Fallara G, Capogrosso P, Schifano N, Costa A, Candela L, Cazzaniga W, et al. Ten-year follow-up results after holmium laser enucleation of the prostate. Eur Urol Focus. 2021;7(3):612–7.PubMedCrossRef

21.

Kavoussi NL, Nimmagadda N, Robles J, Forbes C, Wang A, Stone B, et al. MOSESTM technology for holmium laser enucleation of the prostate: a prospective double-blind randomized control trial. J Urol. 2021;206(1):104–8.PubMedCrossRef

22.

Nevo A, Faraj KS, Cheney SM, Moore JP, Stern KL, Borofsky M, et al. Holmium laser enucleation of the prostate using Moses 2.0 vs non-Moses: a randomised controlled trial. BJU Int. 2020;127(5):553–9.PubMedCrossRef

23.

Elshal AMSM, El-Tabey NA, Laymon M, Nabeeh A. Randomised trial of bipolar resection vs holmium laser enucleation vs greenlight laser vapo-enucleation of the prostate for treatment of large benign prostate obstruction: 3-years outcomes. BJU International. 2020;126:731–8.PubMedCrossRef

24.

Assmus MA, Large T, Krambeck A. Holmium laser enucleation of the prostate efficiency by prostate gland size: is there a sweet spot? Uro. 2021;1(4):202–8.CrossRef

25.

Dusing MW, Krambeck AE, Terry C, Matlaga BR, Miller NL, Humphreys MR, et al. Holmium laser enucleation of the prostate: efficiency gained by experience and operative technique. J Urol. 2010;184(2):635–40.PubMedCrossRef

26.

Whiles BB, Martin AJ, Brevik A, Carrera RV, Thompson JA, Molina WR, et al. Utilization of MOSES modulated pulse mode results in improved efficiency in holmium:YAG laser ablation of the prostate. Urology. 2021;149:187–92.PubMedCrossRef

27.

Assmus MAGMB, Lee MS, Large T, Krambeck AE. Contemporary outcomes for patients undergoing concurrent surgeries at the time of holmium laser enucleation of the prostate before and after moses 2.0 BPH mode. J Endourol. 2021;35(53):58–513.

28.

Assmus MA, Lee MS, Sivaguru M, Agarwal DK, Large T, Fouke BW, et al. Laser fiber degradation following holmium laser enucleation of the prostate utilizing Moses technology versus regular mode. World J Urol. 2022;40(5):1203–9.PubMedCrossRef

29.

Large T, Nottingham C, Stoughton C, Williams J Jr, Krambeck A. Comparative study of holmium laser enucleation of the prostate with MOSES enabled pulsed laser modulation. Urology. 2020;136:196–201.PubMedCrossRef

30.

Nottingham CU, Large T, Agarwal DK, Rivera ME, Krambeck A. Comparison of newly-optimized Moses technology versus standard holmium:YAG for endoscopic laser enucleation of the prostate. J Endourol. 2021;35(9):1393–9.PubMed

31.

Enikeev D, Morozov A, Taratkin M, Misrai V, Rijo E, Podoinitsin A, et al. Systematic review of the endoscopic enucleation of the prostate learning curve. World J Urol. 2020;39(7):2427–38.PubMedCrossRef

32.

Gurlen G, Karkin K. Does Holmium laser enucleation of the prostate (HoLEP) still have a steep learning curve? Our experience of 100 consecutive cases from Turkey. Arch Ital Urol Androl. 2021;93(4):412–7.PubMedCrossRef

33.

Yuan QWS, Huang B, Xu Z, Li D, Li J, Fu W, Zhang X. MOSESTM technology for holmium laser enucleation of the prostate a prospective double-blind randomized control trial. Letter Journal of Urology. 2021;206(3):785–6.PubMedCrossRef

34.

Gauhar V, Gilling P, Pirola GM, Chan VW, Lim EJ, Maggi M, et al. Does MOSES technology enhance the efficiency and outcomes of standard holmium laser enucleation of the prostate? Results of a Systematic Review and Meta-analysis of Comparative Studies. Eur Urol Focus. 2022;8(5):1362–9.PubMedCrossRef

35.

Klett DE, Baird B, Ball CT, Dora CD. Does MOSES pulse modulation reduce short-term catheter reinsertion following holmium laser enucleation of the prostate? Investig Clin Urol. 2021;62(6):666–71.PubMedPubMedCentralCrossRef

36.

Comat V, Marquette T, Sutter W, Bernhard JC, Pasticier G, Capon G, et al. Day-case holmium laser enucleation of the prostate: prospective evaluation of 90 consecutive cases. J Endourol. 2017;31(10):1056–61.PubMedCrossRef

37.

Lee SM, Gordon K, McMillan R, Crystal F, Acher P. Day-case holmium laser enucleation of the prostate: feasibility, safety and predictive factors. Ann R Coll Surg Engl. 2018;100(6):475–9.PubMedPubMedCentralCrossRef

38.

Lwin AA, Zeng J, Evans P, Phung MC, Hynes KA, Price ET, et al. Holmium laser enucleation of the prostate is safe and feasible as a same day surgery. Urology. 2020;138:119–24.PubMedCrossRef

39.

Lee MS, Assmus M, Agarwal D, Large T, Krambeck A. A cost comparison of holmium laser enucleation of the prostate with and without Moses™. Urology Practice. 2021;8(6):624–9.PubMedCrossRef

Title: Moses Laser Enucleation of the Prostate (MoLEP): Use of Pulse Modulated Holmium Laser Technology for Prostate Enucleation
Authors: Mark A. Assmus
Amy E. Krambeck
Publication date: 01-04-2023
Publisher: Springer US
Keywords: Benign Prostatic Hypertrophy
Benign Prostatic Hypertrophy
Laser
Published in: Current Bladder Dysfunction Reports / Issue 2/2023
Print ISSN: 1931-7212
Electronic ISSN: 1931-7220
DOI: https://doi.org/10.1007/s11884-023-00698-3

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Moses Laser Enucleation of the Prostate (MoLEP): Use of Pulse Modulated Holmium Laser Technology for Prostate Enucleation

Abstract

Purpose of Review

Recent Findings

Summary

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Purpose of Review

Recent Findings

Summary

Please log in to get access to this content

Other articles of this Issue 2/2023

Managing Pelvic Organ Prolapse After Urinary Diversion or Neobladder

Genetic, Genomic, and Heritable Components of Benign Prostatic Hyperplasia

Botulinum Toxin Therapy for Bladder Pain Syndrome/Interstitial Cystitis

Pathophysiological Mechanisms Involved in Overactive Bladder/Detrusor Overactivity

Mechanisms of Action for Diabetic Bladder Dysfunction — State of the Art

Diagnosing and Managing Bladder Outlet Obstruction with Detrusor Underactivity in Males